ACADEMY OF MANAGED CARE PHARMACY for ACADEMY OF MANAGED CARE PHARMACY
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Submitted comments to CMS on Medicare Advantage and Medicare Part D Rule, joined other stakeholders in letter HHS OIG in support of a safe harbor provision for that would encourage development of value-based contracts for the Medicare and Medicaid populations,submitted comments to CMS on the 2019 draft Call letter and submitted letter to Rep. Schweikert in support of H.R. 4148 concerning standardizing electronic prior authorization for Medicare beneficiaries.
| Lobbyist | Covered position, as disclosed |
|---|---|
| REGINIA GRAYSON BENJAMIN | Director of Legislative Affairs |
| MARY JO CARDEN | Vice President, Government & Pharmacy Affairs |
Pharmacy PHA
Joined other stakeholders in a letter to Reps. Mullin and Blumenauer of support for H.R. 3545 - Overdose Prevention and Patient Safety Act, also sent a letter of support of H.R. 3545 to House Energy and Commerce Committee in support of H.R.3545 , Joined other stakeholders in letter to Senate and House leadership in support of the CREATES Act (H.R.2212 and S. 974) Delivered remarks at FDA Opioid Policy Steering Committee on ways to address the opioid epidemic, dissemination of pharmacoeconomic information,submitted letter to House Energy and Commerce Committee in support of H.R. 2026 Pharmaceutical Information Exchange Act and submitted a letter to AHRQ in response to a request for information regarding patient reported outcomes measures.
| Lobbyist | Covered position, as disclosed |
|---|---|
| REGINIA GRAYSON BENJAMIN | — |
| MARY JO CARDEN New | Vice President, Government & Pharmacy Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.